Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Works matching IS 11727047 AND DT 2018 AND VI 32 AND IP 6
Results: 10
1
2
Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview.
- Published in:
- 2018
- By:
- Publication type:
- journal article
3
A Systematic Review and Meta-Analysis of the Risk of Dementia Associated with Benzodiazepine Use, After Controlling for Protopathic Bias.
- Published in:
- 2018
- By:
- Publication type:
- journal article
4
Tailoring Treatment in Polymorbid Migraine Patients through Personalized Medicine.
- Published in:
- 2018
- By:
- Publication type:
- journal article
5
Correction to: Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents.
- Published in:
- 2018
- By:
- Publication type:
- journal article
6
Correction to: Gadolinium-Based Contrast Agent-Related Toxicities.
- Published in:
- 2018
- By:
- Publication type:
- journal article
7
Systemic Therapy of Lung Cancer CNS Metastases Using Molecularly Targeted Agents and Immune Checkpoint Inhibitors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
8
Polypharmacy Among Headache Patients: A Cross-Sectional Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
9
Prescription of Zolpidem and the Risk of Fatal Motor Vehicle Collisions: A Population-Based, Case-Crossover Study from South Korea.
- Published in:
- 2018
- By:
- Publication type:
- journal article
10
Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer's Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article